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Summary
Objective: The main aim of the present study was to determine the sensitivity, speciﬁcity and accuracy of ultrasonography (US) in detecting
monosodium urate and calcium pyrophosphate dihydrate crystals deposits at knee cartilage level using clinical deﬁnite diagnosis as standard
reference.
Design: A total of 32 patients with a diagnosis of gout and 48 patients with pyrophosphate arthropathy were included in the study. Fifty-two
patients with rheumatoid arthritis (RA), psoriatic arthritis or osteoarthritis (OA) were recruited as disease controls. All diagnoses were made
using an international clinical criterion. US examinations were performed by an experienced sonographer, blind to clinical and laboratory data.
Hyaline cartilage was assessed to detect two US ﬁndings recently indicated as indicative of crystal deposits: hyperechoic enhancement of the
superﬁcial margin of the hyaline cartilage and hyperechoic spots within the cartilage layer not generating a posterior acoustic shadow.
Results: Hyperechoic enhancement of the chondrosynovial margin was found in at least one knee of 14 out of 32 (43.7%) patients with gout
and in a single knee of only one patient affected by pyrophosphate arthropathy (speciﬁcity¼ 99%). Intra-cartilaginous hyperechoic spots were
detected in at least one knee of 33 out of 48 (68.7%) patients with pyrophosphate arthropathy and in two disease controls one with OA and the
second with RA (speciﬁcity¼ 97.6%).
Conclusions: The results of the present study indicate that US may play a relevant role in distinguishing cartilage involvement in patients with
crystal-related arthropathy. The selected US ﬁndings were found to be highly speciﬁc.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Ultrasound, Crystals, Cartilage, Gout, Calcium pyrophosphate deposition disease, Knee.Introduction
Ultrasonography (US) has been shown to be a feasible and
reliable imaging tool for the visualization of the articular
cartilage1e9. Last generation US equipment allows for
a high resolution imaging of the normal US features and
the detection of even minimal morphostructural changes
of the hyaline cartilage1,8,9. Despite its potential, very little
data is currently available in literature relating to this topic.
Cartilage is a common target of different rheumatic
diseases including crystal-related arthropathies. Hyaline
cartilage of the knee represents one of the most frequently
involved site where crystals deposit and femoral cartilage at
knee level can be widely explored by US1,10e12.
The main aim of the present study was to determine the
sensitivity, speciﬁcity and accuracy of US in detecting
monosodium urate (MSU) and calcium pyrophosphate dihy-
drate (CPPD) crystals deposition at knee cartilage level
using clinical deﬁnite diagnosis as standard reference. A*Address correspondence and reprint requests to: Emilio
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178secondary aim of the study was to assess the interobserver
agreement in the detection of US ﬁndings indicative of crys-
tals deposition at cartilage level.MethodPATIENTSA total of 32 patients with a diagnosis of gout, made using the American
Rheumatism Association guidelines13 and 48 patients with pyrophosphate
arthropathy diagnosed according to McCarty criteria14, were included in
the present study. Fifty-two patients with rheumatoid arthritis (RA), psoriatic
arthritis (PA) or osteoarthritis (OA) diagnosed using international clinical cri-
teria, were recruited as disease controls15e17. Patients were selected from
those attending the out-patient and in-patient clinics of the Rheumatology
Department of the Universita` Politecnica delle Marche. Table I summarises
patients’ demographic and clinical data.STUDY DESIGNThe study was conducted according to the Declaration of Helsinki and
local regulations. US examinations were performed by an experienced
sonographer, blind to clinical and laboratory data. Patients were asked not
to talk about their clinical condition with the US examiner. A second investi-
gator with less than 1 year of experience carried out US examinations in 30
patients: 10 with gout, 10 with pyrophosphate arthropathy and 10 disease
controls. Prior to the study, the investigators reached a consensus on the
US scanning technique to adopt and on US ﬁndings to detect.
Table I
Patients demographic and clinical data
Patients with
gout
Patients with
pyrophosphate arthropathy
Disease controls
Number of patients 32 48 52 (20 with RA, 16 with
PA, 16 with OA)
Sex (female/male) 0/32 37/11 42/10
Age in years (median; 95% CI for
the median; SD; range)
65; 54e71;
11.6; 39e80
64.5; 62e68; 10.3;
26e84
66; 60.9e72; 13.6;
30e87
Number of patients with hyperechoic enhancement
of the superﬁcial margin
14 1 0
Number of patients with hyperechoic spots within
the cartilage layer
0 33 2 (one with OA and
one with RA)
SD¼ standard deviation.
179Osteoarthritis and Cartilage Vol. 17, No. 2US IMAGE ACQUISITIONThe US scanning technique adopted the standard scans for the assess-
ment of knee cartilage described in the european league against rheumatism
(EULAR) guidelines for musculoskeletal ultrasound in rheumatology, includ-
ing suprapatellar views with knee in maximal ﬂexion and posterior views with
knee extended18. Additional scans, performed to assess a wider cartilage
surface, included parapatellar views which were carried out with knee in
maximal ﬂexion. Both medial and lateral aspects of the femoral cartilage
not covered by the patella were explored on both longitudinal and transverse
views. A detailed description of the scans adopted in the present study is re-
ported in Table II. To obtain the maximal exposure of the femoral cartilage
surface, all the patients were asked to obtain the maximal degree of knee
ﬂexion. The inclination of the US beam was adjusted to obtain a direction
perpendicular to the cartilage surface. A dynamic examination was carried
out to distinguish the superﬁcial margin of the cartilage.
US examinations were performed using a MyLab 70 XVG (Esaote Bio-
medica, Genoa, Italy), equipped with a broadband 6e18 MHz linear probe.US IMAGE INTERPRETATIONHyaline cartilage was assessed to detect two US ﬁndings indicative of
crystal deposits: hyperechoic enhancement of the superﬁcial margin of the
hyaline cartilage and hyperechoic spots within the cartilage layer not generat-
ing a posterior acoustic shadow8,19e26. Figure 1 shows representative images
of both US ﬁndings. The ﬁrst ﬁnding was interpreted as the US feature of MSU
crystal deposits on the cartilage surface. The second ﬁnding was used for
identifying CPPD crystal deposits within the hyaline cartilage texture.STATISTICAL ANALYSISData was statistically analysed using the MedCalc software package (Ver-
sion 9.3 for Windows). Correlation between binary data was calculated using
the Fisher’s exact test. The level of signiﬁcance was P< 0.05. Interobserver
reliability was estimated calculating the unweighted kappa values, the intra-
class correlation coefﬁcients and the percentages of exact agreement.Results
A total of 264 knees in 132 patients were assessed.
Hyperechoic enhancement of the chondrosynovial margin
was found in at least one knee in 14 out of 32 (43.7%)Table I
Scanning technique for the assessment of the femoral hyaline cartilage of
EULAR Working Group for Musculoskeletal Ultraso
Scanning planes Position of the pati
Anterior suprapatellar transverse and
longitudinal scans
Patient in supine position
knee in maximal ﬂexion (
Anterior parapatellar transverse and
longitudinal scans
Patient in supine position
knee in maximal ﬂexion (
Posterior transverse and longitudinal
scans
Patient in prone position
knee extendedpatients with gout and in a single knee of only one patient
affected by pyrophosphate arthropathy [Table III(A)]. Intra-
cartilaginous hyperechoic spots were detected in at least
one knee of 33 out of 48 (68.7%) patients with pyrophos-
phate arthropathy and in two disease controls one with
OA and the second with RA [Table III(B)].
Figure 2 demonstrates the distribution of both hypere-
choic enhancement of the chondrosynovial margin and
hyperechoic spots within the cartilage layer in different
areas of the articular cartilage of the femoral condyles
according to the US views used in the scanning protocol.
Fourteen, 22 and seven out of 43 US ﬁndings of hypere-
choic enhancement of the chondrosynovial margin
(32.6%, 51.1% and 16.3%) were obtained using, respec-
tively, the suprapatellar, parapatellar and posterior views.
Sixty, 43 and 20 out of 123 US ﬁndings of hyperechoic
spots within the cartilage layer (48.8%, 34.9% and 16.3%)
were obtained using, respectively, the suprapatellar, para-
patellar and posterior views.
Exact agreement between the two sonographers was
seen in 92.7% of the 180 scans with regard to hyperechoic
enhancement of the chondrosynovial interface and in 90%
with regard to hyperechoic spots within the cartilage layer.
Corresponding intraclass correlation coefﬁcient values
were 0.5695 (P< 0.0001; 95% conﬁdence interval (CI):
0.4617e0.6607) and 0.72, respectively, while unweighted
kappa values were 0.68 and 0.55, respectively.
Discussion
Despite gout and CPPD disease are not rare conditions,
only few studies investigated the role of US in patients with
crystal-related arthropathies8,19e28.
To the best of our knowledge, this is the ﬁrst study that
assessed the diagnostic value of US in the assessment of
knee cartilage involvement in patients with crystal-related
arthropathies.I
the knee. Further information is freely available on the website of the
und (http://www.doctor33.it/eular/ultrasound/)
ent Visualized area
with the
>90()
Hyaline cartilage of the femoral trochlea and the
anterior portion of the femoral condyles
with the
>90()
The lateral portion of the hyaline cartilage of the
femoral condyles not covered by the patella
with the Hyaline cartilage of the posterior portion of the
femoral condyles
Table III
Distribution of the US findings among different diseases
Hyperechoic enhancement of the
superﬁcial margin
Present Absent Total
(A) Frequency table. US finding of MSU crystal deposition and
rheumatic diseases
Clinical
deﬁnite
diagnosis
Gout 14 18 32 (24.2%)
Pyrophosphate
arthropathy, RA,
PA or OA
1 99 100 (75.8%)
Total 15 (11.4%) 117 (88.6%) 132
Hyperechoic spots within the cartilage
layer
Present Absent Total
(B) Frequency table. US finding of CPPD crystal deposition and
rheumatic diseases
Clinical
deﬁnite
diagnosis
Pyrophosphate
arthropathy
33 15 48 (36.4%)
Gout, RA,
PA or OA
2 82 84 (63.6%)
Total 35 (26.5%) 97 (73.5%) 132
(A) Sensitivity¼ 43.7%; speciﬁcity¼ 99%; and accuracy¼ 85.6%.
(B) Sensitivity¼ 68.7%; speciﬁcity¼ 97.6%; and accuracy¼ 87.1%.
Fig. 2. Distribution of the percentages of US ﬁndings at knee
femoral cartilage as detected using different US views.
Fig. 1. Hyaline cartilage of the femoral condyle. (A) Healthy subject.
Hyaline cartilage is delimited by two hyperechoic and sharp
margins. The superﬁcial margin (chondrosynovial interface) (curved
arrow) is typically thinner than the deeper margin (osteochondral
interface). Cartilage echotexture is homogeneously anechoic. (B)
Gout. Hyperechoic enhancement of the chondrosynovial interface
due to MSU crystal deposition on the cartilage surface (arrows).
(C) CPPD crystal deposition disease. Loss of the normal homoge-
nicity of the cartilage echotexture due to the presence of hyper-
echoic spots (arrowheads). f¼ femur.
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made according to international clinical criteria, was used
as gold standard to determine the sensitivity, speciﬁcity
and accuracy of US in the detection of pathological
ﬁndings indicative of crystal depositions at knee cartilage
level.
Femoral cartilage of the knee was investigated because it
is frequently involved in patients with crystal deposition dis-
easesand largeextent of its surface canbeexploredbyUS10.
The results of the present study indicate that US may play
a relevant role in distinguishing cartilage involvement in
patients with crystal-related arthropathy. The selected US
ﬁndings were found to be highly speciﬁc. The distribution
of crystal deposits at cartilage level is mainly related to
the site of their formation: synovial cells for urate crystals
and hyaline cartilage for CPPD crystals29. The US ﬁndings
indicative of crystal deposits assessed in the present study
were both found in the same joint of only one patient with
diagnosis of pyrophosphate arthropathy. A possibleexplanation of such condition is the ‘‘shedding’’ of the
CPPD crystals into the joint space and their subsequent de-
position on the cartilage surface.
The relatively low sensitivity of US has an explanation in
the study design. Patients with deﬁnite diagnosis had their
femoral cartilage examined also in the absence of a history
of clinically involved knee. US sensitivity can be increased
extending US assessment to other tissues (i.e., ﬁbrocarti-
lage, tendons)8,30 and anatomic sites (i.e., wrist, ﬁrst meta-
tarsophalangeal joint)19,20 and including other US ﬁndings
indicative of crystals deposition such as tophaceous de-
posits and meniscal calciﬁcations8,19,20,30e32. Moreover,
the pathological ﬁndings investigated in the present study
181Osteoarthritis and Cartilage Vol. 17, No. 2should be evaluated also in the light of clinical joint involve-
ment and/or of other US features indicative of hyaline carti-
lage damage including circumscribed or diffuse thinning of
the cartilage layer and irregularities of the cartilage margins.
Thus, further studies are needed to reﬁne the diagnostic
value of US in patients with crystal-related arthropathies.Conﬂict of interest
All authors declare no conﬂict of interests.References
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